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Proopiomelanocortin (POMC) is a precursor poly-
peptide for various bioactive peptides, including adreno-
corticotropic hormone, a-, b-, and g-melanotropin, b-
endorphin, and b-lipotropin. Although the classical
source of POMC is the pituitary, various studies indicate
the expression of POMC in several nonpituitary tissues.
In this study, in situ hybridization with anti-sense cRNA
riboprobe was used to show expression of POMC mRNA
in human epidermis and cultured human epidermal cells
(melanocytes and keratinocytes). POMC mRNA was
amplified by reverse transcriptase-polymerase chain
reaction using anti-sense and sense primers designed
Proopiomelanocortin (POMC) is an µ30,000 dalton pre-cursor protein for a variety of bioactive peptides (Smithand Funder, 1988), adrenocorticotropic hormone (ACTH),α-, β-, and γ-melanotropin (MSH), β-endorphin, andβ-lipotropin. All of these are derived by tissue-specific
post-translational proteolytic cleavage from POMC (Evans et al, 1983).
In the anterior lobe of the pituitary the major secretory products
are ACTH and β-lipotropin, whereas in the intermediate lobe the
predominant products are α-MSH and corticotropin-like intermediate
product (Mains et al, 1977; Crine et al, 1978). This proteolytic
processing is mediated by prohormone convertase 1 and 2 (Bloomquist
et al, 1991; Lindberg, 1991). Prohormone convertase 1 cleaves POMC
to ACTH and β-lipotropin, whereas prohormone convertase 2 cleaves
POMC into β-endorphin from β-lipotropin, generating α-MSH and/
or des-acetyl-α-MSH by further cleavage of ACTH (Bloomquist et al,
1991; Lindberg, 1991).
The POMC gene encodes the precursor to various POMC peptides
and has three Exons and two introns. Exon 1 contains a noncoding
region, Exon 2 encodes a signal peptide essential to protein processing
and secretion (Autelitano et al, 1989). Exon 3 encodes various bioactive
peptides, such as ACTH, α-, β-, and γ-MSH, β-endorphin, and β-
lipotropin. Splicing of the primary POMC mRNA transcript results
in µ1100 nucleotides POMC mRNA (Autelitano et al, 1989). It has
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from Exons 2 and 3 of POMC gene. A µ300 bp product
was present in normal human skin, grafted human
skin, and cultured normal human melanocytes and
keratinocytes. By Southern analysis this product was
hybridized specifically to the POMC cDNA. Sequence
analysis of the reverse transcriptase polymerase chain
reaction product from tissues or cells showed 85% homo-
logy to POMC cDNA from human, bovine, pig, and
monkey sources. This suggests the existence of a putative
isoform or variant of POMC mRNA in human epidermis.
Key words: in situ hybridization/keratinocyte/melanocyte/
POMC/RT-PCR. J Invest Dermatol 111:485–491, 1998
been shown that the mouse genome contains two POMC related gene
sequences, α-POMC and β-POMC (Uhler et al, 1983). The functional
α-POMC in mouse is very similar to the single gene expressed in
human, bovine, and rat genome (Uhler et al, 1983). α- and β-POMC
genes map to mouse chromosomes 12 and 19, respectively. The β-
POMC locus may contain a pseudogene (Uhler et al, 1983).
The POMC is expressed in the pituitary gland, its traditional source,
and in the hypothalamus, amygdala, and cerebral cortex. POMC
expression also occurs in the ovary and testis, adrenal medulla, spleen,
duodenum, and stomach (Pintar et al, 1984). POMC mRNA and its
derived peptides have also been detected in cells of the immune system
(Blalock, 1985). Our recent results showed the presence of POMC
and its derivative peptides in murine epidermal cells and Thy-11
dendritic cells (Farooqui et al, 1995). The latter cells are bone marrow-
derived T lymphocytes found exclusively in murine epidermis. In
human skin, α-MSH was the first POMC-derived peptide to be
identified (Thody et al, 1983). Subsequently, POMC peptides were
found in keratinocytes (Slominski et al, 1993a; Schauer et al, 1994;
Chakraborty et al, 1995, 1996; Kippenberger et al, 1995; Wintzen et al,
1996), melanocytes (Farooqui et al, 1993; Kippenberger et al, 1995;
Chakraborty et al, 1996), and Langerhans cells (Morhenn, 1991). It
remains to be determined whether these molecules were synthesized
in situ or transported from other sites.
In this study we show the presence of mRNA for POMC in human
epidermal cells, including melanocytes and keratinocytes, using in situ
hybridization. We have also characterized the POMC-like mRNA
transcripts in epidermal tissue and isolated cells using reverse tran-
scriptase-polymerase chain reaction (RT-PCR). These data prove that
POMC is synthesized in the epidermis. Partial sequence of isolated
POMC mRNA transcript from human skin, melanocytes, and ker-
atinocytes indicates that the POMC-like mRNA is an isoform or
variant of pituitary POMC.
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The significance of these results lies in the important pleiotropic
effects of POMC-derived peptides on the skin. The POMC-derived
peptides play key roles in the communication between the immune
system and the neuroendocrine system (Blalock, 1989; McCubbin
et al, 1991). α-Melanocyte stimulating hormone has potent anti-
inflammatory effects that include blockage of chemotaxis of neutrophils,
activation of B and T lymphocytes, release of acute-phase reactants
from the liver, fever induction by interleukin-1, inflammation induced
by chemicals (crude oil), ultraviolet (UV) radiation and psoralen-UVA,
or allergic contact dermatitis. It has been suggested that α-MSH also
plays a role in the pathogenesis of cutaneous contact hypersensitivity
(Rheins et al, 1989). Furthermore, α-MSH and interleukin-1 have
antagonistic interaction and interleukin-1 antagonizes the melano-
genic effect of α-MSH on melanocytes (Daynes et al, 1987; Swope
et al, 1989).
α-MSH plays a major role in stimulating integumental pigmentation
(Sawyer et al, 1983; Sherbrooke et al, 1988). It causes rapid color
change in lower vertebrates and coat color darkening in mammals.
α-MSH and ACTH directly stimulate proliferation and melanogenesis
of cultured human melanocytes and α-MSH augments the melanogenic
effects of UV light on these cells (Abdel-Malek et al, 1995; Suzuki
et al, 1996; Im et al, 1998). The biologic effects of α-MSH suggest
that it might be a transducer of the UV-induced effects on human
melanocytes (Bolognia et al, 1989; Chakraborty et al, 1991; Im
et al, 1998).
MATERIALS AND METHODS
Cell cultures and human skin Cultures of normal human melanocytes from
neonatal foreskins obtained from Caucasian (skin types I–III) and/or African
American (skin type V) newborns were established and maintained according
to the procedure described previously (Abdel-Malek et al, 1995). Cultures of
normal human keratinocytes were obtained as previously reported (Boyce and
Ham, 1985). The melanocyte and keratinocyte growth media contain bovine
pituitary extract (BPE) that contains micromolar concentrations of α-MSH and
possibly ACTH (Abdel-Malek et al, 1995). Both melanocytes and keratinocytes
require BPE for their growth and proliferation in culture. For that, stock
cultures were grown in BPE containing medium. Cells were deprived of BPE
for 48–72 h prior to experiments, and were maintained in BPE-free medium
for the experimental duration. AtT20 cells were obtained from American Type
Culture Collection and were maintained in suspension according to the
supplier’s instructions. Biopsies (4 mm) of normal human skin were obtained
from consenting Caucasian (skin types I–III), Chinese American (skin type IV),
and/or African American (skin type V) volunteers in our department using an
IRB approved protocol (IRB #88–09–09–01).
Riboprobe preparation A human POMC cDNA containing plasmid pH-
OX3, a gift from Dr. James L. Roberts (Mount Sinai Medical Center, NY),
was used for cRNA riboprobe preparation. Restriction digestion of pH-OX3
with Hind III gave an µ1146 bp fragment that included full Exon 3 containing
coding region (833 bp) and 39 noncoding sequence (313 bp) (Takahashi et al,
1983), which was subcloned into PGEM-3Z expression vector (Promega,
Madison, WI). Vector DNA was digested with Hind III followed by dephospho-
rylation with calf intestinal alkaline phosphatase (Promega). Standard ligation
reaction for vector DNA and insert DNA was carried out (Promega). The
ligation mixture was transformed into JM 109, competent cells (Promega) and
plated on agar plates containing X-gal, IPTG, and ampicillin. We selected two
clones under SP6 promoter direction: clone 1 (sense), which contains a DNA
fragment insert in the 59 → 39, and clone 2 (anti-sense), in which the orientation
was from 39 → 59 (under SP6 promoter direction).
Sense and anti-sense plasmids were linearized by ECoR1. The linearized
templates were treated with proteinase K (0.1 µg per ml) and sodium dodecyl
sulfate (0.1%) at 37°C for 30 min and then purified by phenol and chloroform
extraction. The radiolabeled sense and anti-sense cRNA probes were synthesized
using 1 µg of linearized template and 50 units of SP6 polymerase (Stratagene,
La Jolla, CA) in the presence of 1 3 reaction buffer, 0.4 mM adenosine-
triphosphate, guanosine triphosphate, and thymidine triphosphate, 0.01 mM
uridine triphosphate, 30 mM dithiothreitol, and 40 units RNasin (Promega),
and 200 µci 35S-UTP (Amersham, Arlington Heights, IL; 800 Ci per mmol,
40 mci per ml) was added in each reaction. The in vitro transcription mixture
was allowed to react at 37°C for 3 h. Then the mixture was treated with 1
unit RNase free DNase (Stratagene) for 10 min at 37°C. The reaction product
was extracted once with phenol, isopropyl alcohol, and chloroform in the
presence of 0.1 µg yeast tRNA per ml (BRL, Gaithersburg, MD) and
purified by passing through G-50 sephadex Quick Spin Column (Boehringer,
Indianapolis, IN).
In situ hybridization Skin biopsies (4 mm) were obtained from the forearm
of six consenting normal human subjects and fixed in 4% paraformaldehyde in
phosphate-buffered saline for 2 h, cryoprotected in 30% sucrose overnight,
embedded in OCT (Tissue Tek, Elkhart, IN), and quickly snap frozen at –
80°C. The embedded tissue blocks were stored at –80°C until used. Normal
human melanocytes and keratinocytes were either cytocentrifuged on slides or
grown in eight well chamber slides (Tissue Tek). The frozen skin sections
(7 µm) and cells on Tespa (3-amino propyltriethoxysilane) coated slides were
air dried and postfixed in 4% paraformaldehyde for 1 h. The slides were treated
with proteinase K (20 µg per ml) for 5 min followed by treatment with 0.25%
acetic anhydride in 0.1 M triethanolamine for 10 min, washed, and air-dried
(Witte et al, 1991). Prehybridization was carried out at 42°C for 15 min in
hybridization cocktail containing 2 3 sodium citrate/chloride buffer, 50%
formamide, 10% Dextran sulfate, 0.75 mg yeast tRNA per ml, 0.75 mg herring
sperm DNA per ml, 5 mM dithiothreitol, 0.1 mg bovine serum albumin per
ml, 1 3 Denhardts’ solution, and 0.1 mM thio-UMP. Following prehybridiza-
tion, the sections were hybridized by using 1 3 106 cpm per slide corresponding
anti-sense or sense probes in the hybridization cocktail without thio-UMP at
42°C for 14–16 h with coverslip sealed by Cement (Kindler, Trenton, NJ).
Coverslips were removed and the sections were washed in 1 3 sodium citrate/
chloride buffer and 1 mM dithiothreitol at 50°C for 30 min and then incubated
in RNase T1 at 37°C for 30 min. A series of high stringency wash was
followed. The washing steps started with 50% formamide in 2 3 sodium
citrate/chloride buffer at 50°C, 2 3 30 min, 0.5 3 sodium citrate/chloride
buffer, and finally in 0.1 3 sodium citrate/chloride buffer at 55°C, and
dithiothreitol was added to a final concentration of 1 mM. After dehydration
and drying, slides were dropped in Kodak NTB2 emulsion, stored at 4°C, and
developed after 5–14 d.
As a positive control, mouse anterior pituitary tumor cell line (AtT20) obtained
from American Type Culture Collection was included throughout in situ
hybridization experiments.
Combination of immunohistochemistry and in situ hybridiza-
tion Biopsies from normal human skin were processed as described above.
The tissue sections were first subjected to immunohistochemical staining to
identify epidermal melanocytes and keratinocytes. A melanocyte specific anti-
body (Mel-5) (Signet Labs, Dedham, MA) that recognizes TRP-1 epitope was
used to identify melanocyte, whereas cytokeratin antibody (Zymed Labs, San
Francisco, CA) that specifically stains low molecular weight acidic keratins was
employed for keratinocyte identification in the tissue sections. The sections
were stained using avidin-biotinylated horseradish peroxidase Vector kit (Vector
Laboratory, Burlingame, CA) except that all the solutions were prepared in
DEPC-treated water. Following immunohistochemical staining, the sections
were subjected to in situ hybridization as described above.
Total RNA extraction Total RNA used for RT-PCR was isolated using
TRI REAGENT method (Molecular Research Center, Ohio). Briefly, normal
human skin and grafted human skin were homogenized in TRI REAGENT
(50–100 mg tissue per ml) using Polytron homogenizer. Cultures of human
melanocytes and keratinocytes were lyzed directly in the culture flask using
TRI REAGENT and collected in microfuge tubes. After phenol-chloroform
extraction, the RNA was precipitated with isopropanol and the pellet was
rehydrated in DEPC-H20. RNA samples extracted from normal human skin,
grafted human skin, cultured human melanocytes, and keratinocytes were
purified using Message Clean kit (GeneHunter, Nashville, TN). RNA was
treated with 10 units RNase-free DNase 1 for 30 min at 37°C. After phenol-
chloroform extraction RNA was precipitated by adding 3 M sodium acetate
and 100% EtOH for 1 h at –70°C. The RNA pellet was washed once with
70% EtOH and briefly air-dried. RNA was re-dissolved in DEPC-treated water
and quantitated.
Reverse transcription reaction Partial sequence representing Exon 2
(Primer 1) and Exon 3 (Primer 2) was used in the synthesis of the primers:
Primer 1, 59-AGG ACC TCA CCA CGG AAA GCA ACCT-39 (sense);
Primer 2, 59-AGT GCT CCA TGG AGT AGG AGC GCT T-39 (anti-sense).
Reverse transcription was performed using oligod(T)16 as primer. The reverse
transcriptase mixtures contained 0.8 µg of cleaned RNA, 2.5 unit Murine
Leukemia Virus Reverse Transcriptase, 1 unit RNase inhibitor, 2.5 mM
oligod(T)16, 1 mM of dGTP, 1 mM dATP, 1 mM dCTP, 1 mM dTTP, 5 mM
MgCl2, and 10 3 PCR buffer II (Perkin Elmer). The reaction was carried out
at 42°C for 15 min, 99°C for 5 min, and 5°C for 5 min on Perkin-Elmer
Gene Amp PCR system 9600.
Polymerase chain reaction (PCR) PCR was performed in 100 µl con-
taining the reverse transcriptase mix (from above) and 80 µl of PCR master
mix including 2 mM MgCl2, 1 3 PCR buffer II, 0.15 µM Primer 1, 0.15 µM
Primer 2, and 2.5 unit of Ampli-Taq DNA Polymerase. The reaction was
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carried out using the following conditions: initial denaturization at 75°C for
105 s, 35 cycles at 95°C for 15 s, 60°C for 30 s, and finally 72°C for 7 min.
The products were electrophoresed on a 1.5% agarose gel. For negative control
the following conditions were used: 1, RNA was not added in reverse
transcriptase mix; 2, amplified RNA without reverse transcriptase; 3, PCR
with no cDNA as template. None of the negative control lanes showed
any bands.
Southern blotting The PCR products were subjected to Southern blot
analysis following standard procedure (Sambrook et al, 1989). The PCR products
were run on 1.5% agarose gel, denatured in 0.5 M NaOH, 1.5 M NaCl, and
transferred to nylon membrane. After UV cross-linking, the membrane was
prehybridized in solution containing 1% sodium dodecyl sulfate and Formamide
at 42° for 4 h. [α-32p]dCTP-labeled human POMC cDNA was added to fresh
hybridization buffer and incubation was performed at 42°C overnight. The
membrane was washed three times according to the protocol. After final rinse,
the membrane was exposed to a X-ray film (Kodak, Rochester, NY) for 2 h
at –70°C.
Sequence analysis RT-PCR products were ligated into pCR 2.1C vector
(TA cloning kit, Invitrogen, CA) and 2 µl of ligation mixture was transformed
into One Shot competent cells and plated on LB-ampicillin agar plate. After
incubation of the plates at 37°C overnight, white colonies were picked and
placed in LB ampicillin medium overnight at 37°C, 225 r.p.m. The digestion
of plasmid DNA with ECoR1 gave a µ300 bp product. The sequence analysis
of the DNA was performed using M13 (Forward/Reverse) primer at the DNA
core facility at University of Cincinnati. The sequencing of DNA from each
sample was carried out at least three times to ensure the sequence reproducibility.
RESULTS
Tissue localization of POMC mRNA in human epidermis
Figure 1 shows the result of in situ hybridization of a representative
human skin specimen. The signal for POMC mRNA was specifically
confined in the upper layer of epidermis with anti-sense RNA probe
(Fig 1a, arrowheads). Occasionally, a weak POMC signal was also
observed in the dermis. The autoradiography signal in the dermis
was confined to individual cells, suggesting that endothelial cells or
perivascular cells may also express POMC mRNA. Epidermis labeled
with sense probe was used as a measure of nonspecific labeling (Fig 1b).
Skin biopsies obtained from Caucasian (skin types I–III), Chinese
American (skin type IV), and/or African American (skin type V)
volunteers showed no significant variation in the intensity or pattern
of POMC mRNA signal by in situ hybridization, suggesting similar
expression of POMC in different skin types. These experiments were
performed in triplicate with identical results.
To evaluate the specificity of the in situ hybridization, the cultures
of AtT20 cells were used as a positive control. Our results show a
strong positive signal with the POMC mRNA anti-sense riboprobe
(data not shown), whereas there was only background binding of
POMC mRNA with sense probe. These results indicated that our
anti-sense probe specifically localized to POMC mRNA.
POMC mRNA expression in cultures of normal human melano-
cytes and keratinocytes Prior to in situ hybridization, the BPE was
eliminated from cultures of melanocytes and keratinocytes to eliminate
exogenous concentrations of α-MSH or ACTH present in BPE. A
strong positive labeling with anti-sense probe was observed in cultures
of melanocytes (data not shown). Labeling with sense probe was used
as an indication of nonspecific labeling. Although a number of
melanocytes were present in the culture, no specific labeling to the
cells was noticed with sense probe. Cultures of keratinocytes also
showed labeling with anti-sense probe, whereas no specific signal
for POMC mRNA was demonstrated with sense probe (data not
shown). These results indicate that human epidermal melanocytes and
keratinocytes in culture are capable of expressing POMC mRNA.
Both cultures of melanocytes and keratinocytes established from
Caucasian and/or African American donors did not reveal any variation
in the intensity or pattern of POMC mRNA signal by in situ
hybridization. These experiments were carried out in triplicate to
confirm the intensity and pattern of the POMC mRNA signal.
In vivo identification of the cell types expressing POMC mRNA
in human epidermis A combination of immunohistochemical stain-
Figure 1. Expression of POMC mRNA in human epidermis by in situ
hybridization. Skin biopsies (4 mm) from normal human subjects were
removed and fixed in paraformaldehyde for 2 h followed by treatment with
sucrose overnight. Biopsies were embedded in OCT (Tissue Tek) and frozen
at –80°C. Serial sections (7 µm) of skin were subjected to in situ hybridization
using 35S-labeled anti-sense cRNA probe. Photomicrograph of skin showing
positive signal in epidermis by anti-sense probe (a: arrowhead). In situ hybridization
with sense probe did not show any specific signal (b). Scale bars: 100 µm.
ing and in situ hybridization was employed to identify the cell type
(melanocyte and/or keratinocyte) expressing POMC mRNA in human
epidermis. A positive staining with mel-5 antibody that recognizes
TRP-1 epitope, an enzyme found only in melanocytes, was observed
in human epidermis (Fig 2a). When the same sections were subjected
to in situ hybridization a strong positive signal for POMC mRNA was
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Figure 2. Immunocytochemical staining of epidermal melanocytes
followed by in situ hybridization to localize POMC mRNA. Sections of
normal human skin were stained with DEPC-treated Mel-5 antibody to identify
epidermal melanocytes in skin. The same sections were then subjected to in
situ hybridization using anti-sense and sense riboprobe. Skin sections exhibited
positive staining for Mel-5 (arrowhead) and POMC mRNA was detected (a)
with anti-sense POMC riboprobe, whereas no specific signal for POMC
mRNA was detected with sense probe (b), although the melanocytes were still
stained with Mel-5 (b). Scale bar: 50 µm.
detected with anti-sense probe (Fig 2a, arrowheads) and only background
was noticed with sense probe (Fig 2b). In addition, in control where
mel-5 antibody was omitted, only POMC mRNA signal was observed
with anti-sense probe (data not shown). Figure 3(a) shows staining of
human epidermis with cytokeratin antibody that specifically stains low
Figure 3. Immunocytochemical staining of epidermal keratinocytes
followed by in situ hybridization. Immunocytochemical staining of normal
human skin was performed using cytokeratin antibody to identify epidermal
keratinocytes. The sections were then hybridized with POMC mRNA probe
to localize POMC mRNA. A positive staining for keratinocyte was observed
(arrowhead) for cytokeratin and a positive signal for POMC mRNA was noticed
with anti-sense riboprobe (a), whereas no signal was observed with sense
riboprobe (b). Scale bar: 50 µm.
molecular weight acidic keratins that are exclusively expressed by
keratinocytes. The sections were positively stained for POMC mRNA
with the anti-sense cRNA probe (arrowheads). Background signal was
seen with sense riboprobe (Fig 3b). In control where no primary
antibody was added, only the signal for POMC mRNA was observed
by anti-sense probe (data not shown). These data indicate that in
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Figure 4. Expression of POMC mRNA by RT-PCR. Total RNA from
normal human skin, grafted human skin, and normal human melanocytes and
keratinocytes was isolated using TRI-REAGENT following the manufacturer’s
instructions. The isolated RNA was cleaned by message clean kit from
GeneHunter. For RT-PCR, the following 25-mer primers 1 and 2 representing
partial sequence of Exon 2 and 3 of POMC gene were used: Primer 1, 59-
AGG ACC TCA CCA CGG AAA GCA ACCT-39 (sense); Primer 2, 59-AGT
GCT CCA TGG AGT AGG AGC GCTT-39 (anti-sense). RT-PCR was
performed (35 cycles) according to Perkin-Elmer instructions kit. A µ300 bp
product specific to Exon 3 was amplified in all the samples tested (arrowheads).
Figure 4 depicts DNA size marker obtained from Gibco/BRL, containing
DNA/Hae III fragment ranging from 72 to 1353 bp (lane 1), RT-PCR product
in AtT20 cells (lane 2), normal human keratinocyte (lane 3), grafted human
skin (lane 4), normal human skin (lane 5), normal human melanocyte (lane 6),
and no band in negative control without RNA (lane 7).
situ, human epidermal melanocytes and keratinocytes express mRNA
for POMC.
Identification of RT-PCR product in human skin RT-PCR
was utilized to detect POMC transcripts in human skin and epidermal
cells. Using sense and anti-sense primers designed from Exons 2 and
3 of human POMC, respectively, we performed RT-PCR on RNA
purified from normal and grafted human skin and cultures of melano-
cytes and keratinocytes. As shown in Fig 4, predicted µ300 bp RT-
PCR product specific to Exons 2 and 3 of the POMC gene was
obtained in all the above samples analyzed, except in control where
no RNA was added (lane 7). The variation in the intensity of the
bands specifically in normal human melanocytes could not be due to
the variation in sample loading as we used the same concentration of
RNA in RT-PCR experiments. The lower intensity of RT-PCR
product in melanocytes could possibly be due to the presence of low
abundance message of POMC in melanocytes as compared with normal
skin and/or keratinocytes. In addition, no RT-PCR product was found
in samples that were amplified without cDNA and/or amplified
without reverse transcriptase (data not shown). Further identification
of the observed RT-PCR products from skin and epidermal cell
cultures was carried out by Southern blot analysis using 32P labeled
POMC cDNA. Southern blot analysis revealed the presence of µ300 bp
product, which hybridized with cDNA probe (Fig 5). Sequence
analysis of RT-PCR products from normal human skin, grafted human
skin, and cultures of melanocytes and keratinocyte showed identical
sequences. Only a representative sequence obtained from human skin
or cultured cells is given (Fig 6) for comparison with the sequence in
human pituitary. The appearance of a reproducible sequence of RT-
PCR product eliminates any possibility of RT-PCR artifacts, because
the experiment was performed three times independently. Comparison
of nucleic acid sequence by Genebank showed an µ85% homology
with human POMC cDNA (Fig 6). There are 28 differences between
the human pituitary POMC nucleotide sequence data and ours, as
depicted by asterisks in Fig 6. Owing to some of these differences our
deduced amino acid sequence shows the substitution of ala for glu and
that of Leu for pro, leu for ala, pro for arg, and ala for ser. The
Figure 5. Expression of POMC mRNA by RT-PCR Southern blot
analysis. The PCR products obtained under experimental conditions of Fig 4
were subjected to Southern blot analysis to confirm the identity of the product.
After reaction, the bands were transferred onto Nytran membrane and hybridized
using 32P-labeled POMC cDNA probe. Figure 5 shows the presence of
µ300 bp product hybridized to POMC cDNA probe in AtT20 cells (lane 1,
arrow), normal human keratinocytes (lane 2), grafted human skin (lane 3), normal
human skin (lane 4), and normal human melanocyte (lane 5).
Figure 6. A representative sequence of RT-PCR product of POMC
gene obtained from normal human skin, grafted human skin, and
cultures of melanocyte and keratinocytes. RT-PCR products obtained
from human skin and epidermal cells were subcloned into pCR 2.1 vector
using TA cloning kit (Invitrogen, CA) following the manufacturer’s instructions.
Fresh RT-PCR products were ligated into pCR 2.1 in 10 µl ligation mixture
containing 1 µl PCR product, 1 µl 10 3 ligation buffer, 2 µl pCR 2.1 vector,
1 µl T4 DNA Ligase, and 5 µl sterile water. The reaction was carried out by
incubating at 14°C for 6 h. Two microliters of ligation mixture were transformed
into One Shot competent cells and plated on LB agar plate. After incubation
on LB agar plate at 37°C overnight, positive clones were picked up and grown
in a larger volume (100 ml) of LB medium overnight at 37°C. The plasmid
DNA was isolated and incubated with EcoR1 at 37°C for 1 h to confirm the
presence of cloned insert. A µ300 bp insert band was observed on 1.5% agarose
gel. The sequence analysis of the plasmid DNA was performed at the University
of Cincinnati DNA Core Facility. Comparison of the RT-PCR product
sequence with human cDNA (upper panel) indicates an µ85% homology,
suggesting an isoform of POMC mRNA in human skin. Comparison of amino
acid sequence (lower panel) between pituitary and human skin is also depicted.
The differences in nucleotide and amino acid sequences between human skin
and human pituitary are represented by asterisks.
sequence data suggest the presence of an isoform or variant of POMC
gene in human skin.
DISCUSSION
Previous studies from various investigators revealed the presence of
POMC-derived peptides in skin. For example, earlier work by Thody
et al (1983) demonstrated the occurrence of immunoreactive α-MSH
in the skin of humans and other mammals. Subsequent studies
documented the presence of α-MSH and other POMC-derived
peptides such as ACTH and β-lipotropin in epidermis (Farooqui et al,
1993; Slominski et al, 1993b). Both melanocytes and keratinocytes are
capable of expressing POMC-derived peptides (Farooqui et al, 1993;
Kippenberger et al, 1995; Chakraborty et al, 1996; Wintzen et al, 1996).
POMC mRNA transcripts were also detected in human (Vieau et al,
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1989) and rodent melanoma cell lines (Chakraborty et al, 1995) as well as
in cultured human melanocytes (Farooqui et al, 1993; Kippenberger et al,
1995; Chakraborty et al, 1996) and keratinocytes (Kippenberger et al,
1995; Chakraborty et al, 1996; Wintzen et al, 1996). It has been shown
that the POMC-derived melanocortins increase skin pigmentation in
various vertebrate species (Sawyer et al, 1983; Sherbrooke et al, 1988).
Recently, Abdel-Malek et al (1995) have reported that both α-MSH
and ACTH were mitogenic and melanogenic for human melanocytes.
This suggests α-MSH and ACTH might function as autocrine/
paracrine regulators of human pigmentation.
The data presented here provide conclusive evidence that POMC
derivatives are synthesized in human skin in situ. In this study we have
used in situ hybridization with cRNA riboprobe to document the
presence of mRNA for POMC in human epidermis. In human skin
obtained from various normal volunteers, the signal of POMC mRNA
was mostly confined to the epidermis. Occasional staining was also
observed in the dermis, however, possibly localized to endothelial cells
or perivascular cells. The relatively higher signal for POMC mRNA
in human epidermis could partly be due to the fact that both epidermal
keratinocytes and melanocytes express a strong signal for POMC
mRNA as observed by in situ hybridization in this study. Together
these cells constitute substantial cell population in the epidermis; thus
they may contribute to the strong signal. In addition, the extremely
sensitive technique of cRNA in situ hybridization enabled us to detect
a higher signal for POMC mRNA in human skin. Pure cultures of
melanocytes or keratinocytes also express POMC mRNA signal. There
was no striking variation in POMC expression in various strains of
melanocytes and/or keratinocytes derived from different donors. Until
recently various investigators have reported the presence of POMC
mRNA transcripts in human skin as well as isolated cultures of
melanocytes and keratinocytes using northern blot analysis (Farooqui
et al, 1993; Wintzen et al, 1996) or RT-PCR (Kippenberger et al,
1995; Slominski et al, 1995; Wintzen et al, 1996), which involves
extraction/homogenization of tissue for mRNA isolation. In this study
we use in situ hybridization, which has the advantage of a high
resolution localization of POMC mRNA in its original anatomical
context. It also offers the option of single cell resolution for measuring
a biochemical moiety.
In order to identify the cell type expressing POMC mRNA in
normal human skin, a combination of immunohistochemistry and in
situ hybridization was employed. Using a melanocyte specific antibody
(which recognizes TRP-1 epitope) the signal for POMC mRNA
was localized to melanocytes. Similarly a monoclonal antibody that
recognizes various low molecular weight acidic keratins was used for
identification of keratinocytes in normal human skin. Again, a strong
signal for POMC mRNA colocalized with staining of cytokeratin in
keratinocytes, indicating that under normal conditions both melano-
cytes and keratinocytes in situ express POMC mRNA.
Further identification of POMC mRNA in human epidermis as
well as cultures of melanocytes and keratinocytes was performed by
RT-PCR on RNA isolated from these tissues or cells. Using RT-PCR
we were able to show that the POMC gene is expressed in normal
skin, grafted human skin, and cultures of melanocytes or keratinocytes
as determined by the presence of µ300 bp RT-PCR product in these
tissues or cells. The specificity of the RT-PCR product was confirmed
by Southern blot hybridization with 32P-labeled POMC cDNA probe.
The RT-PCR product was successfully hybridized with POMC cDNA,
indicating that the authentic POMC gene product is expressed by
human skin as well as cultured epidermal cells. Using RT-PCR
technique, Slominiski et al (1995) and Kippenberger et al (1995) have
recently shown the presence of POMC mRNA transcripts in normal
human skin, and in melanocytes and keratinocytes, respectively. Con-
sistent with these results and with our previous findings regarding the
increased expression of POMC-related peptides (ACTH and α-MSH)
in grafted human skin, in this study we also detected the presence of
POMC mRNA by RT-PCR.
Additional confirmation of RT-PCR product was carried out by
sequence analysis. RT-PCR products obtained from normal human
skin, grafted human skin, and cultures of melanocytes and keratinocytes
gave an identical sequence (n 5 3). Comparison of sequence by
Genebank revealed a homology of µ85% with human pituitary POMC
cDNA. A similar homology (85%) was also observed with cDNA from
various species such as bovine, porcine, and monkey. This variation in
sequence homology (15%) suggests that the POMC mRNA transcript
in human skin as well as in epidermal cells may represent an isoform
or variant of POMC mRNA. This observation is consistent with other
reports where investigators have shown the presence of POMC mRNA
variants in different tissues (Civelli et al, 1982; Lacaze-Masmonteil et al,
1987; DeBold et al, 1988b; Oates et al, 1988; Slominski et al, 1992;
Farooqui et al, 1995). Slominski (1991) for the first time has shown
the presence of 3.5 kb, 1.5 kb (major), and 1.0 kb (minor) POMC
mRNA transcripts in murine and hamster melanoma cells, thus
providing strong evidence for both larger and shorter POMC mRNA
transcripts under in vivo and in vitro conditions. Also, trout pituitary
expresses larger POMC variants of 1.4 kb and 1.8 kb (Salbert et al,
1992). Similarly, longer variants of POMC mRNA have been reported
in nonpituitary ACTH-producing tumors, thymic carcinoid, and
pancreatic tumor. The processing of the larger mRNA variants in these
tumors quite often differs from processing that takes place in the
pituitary (de Keyzer et al, 1985). On the other hand, using blot
hybridization analysis of POMC RNA, investigators have reported the
presence of small RNA species µ200–400 nucleotides shorter than
the one expressed in the pituitary. The shorter POMC mRNA
transcripts have been reported in normal adrenal glands, ovary, testis,
and thymus in animals (Jeannotte et al, 1987) and in human tissues
(DeBold et al, 1988a; Gallinelli et al, 1995). Similar differences in
transcript size have also been demonstrated in ovaries of rat, mouse,
monkey, and sheep (Chen et al, 1986). Recently, we have reported
the presence of a shorter or truncated POMC mRNA (0.9 kb) in
Thy11 dendritic cells, an epidermal cell of T cell lineage (Farooqui
et al, 1995). Slominski et al (1996) have also demonstrated a shorter
0.9 kb transcript expressed in mouse skin throughout the anagen phase,
whereas 1.1 kb POMC transcript is present exclusively during anagen
V phase of hair growth and is not detected at early phases of hair
growth. It has been postulated that these short POMC mRNA
transcripts may arise as a consequence of alternative splicing, variation
in the length of the poly1 (A) tail, or use of alternative transcription
initiation site (Oates and Herbert, 1984; Jeannotte et al, 1987; Lacaze-
Masmonteil et al, 1987). Lack of Exon 1 and 2 in these transcripts
suggests that the products generated are neither processed nor secreted
(Lacaze-Masmonteil et al, 1987). Using nuclease protection and primer
extension assay, Lacaze-Masmonteil et al (1987) have shown that the
shorter transcripts produced in human testes do not contain 59 coding
sequences and thus may be the products of transcripts initiated from
the 39 end of the second intron rather than alternative processing
of the RNA transcripts initiated at the pituitary promoter. The
heterogeneity of POMC mRNA due to RNA splicing, however, has
been demonstrated in rat pituitary and in AtT20 tumor cell POMC
mRNA (Lacaze-Masmonteil et al, 1987). Although the functional
significance of the heterogeneous/variant POMC mRNA is not clear,
they do appear to vary in a tissue-specific manner. Because in this
study we have compared only µ300 bp of the coding region in Exon
3, which encodes for ACTH, α-MSH, and β-lipotropin, it does not
necessarily conclude whether human skin expresses normal POMC
mRNA like in the pituitary or a variant form reported in peripheral
tissues. In the future therefore it will be crucial to look for any other
variation in the POMC expression in normal and pathologic skin.
The significance of the occurrence of POMC mRNA variant in
normal human skin is unclear at present. One can only speculate that
the variant form of POMC mRNA may contribute to the stability
or half life of the POMC molecule. Because we have detected
immunoreactive POMC peptides such as ACTH, α-MSH, and β-
lipotropin in normal human skin as well as in cultured melanocytes
and keratinocytes,1 suggesting the normal translational products of
POMC by POMC mRNA variants. It will be interesting to identify
1Farooqui J, Gong C, Boyce S, Nordlund J: Expression of pro-
opiomelanocortin and its peptides in human epidermis and epidermal cells.
J Invest Dermatol 106:883, 1996 (abstr.)
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these peptides in detail in order to rule out any possible abnormality/
variation in their structure/sequence. These studies are beyond the
scope of the present investigations; however, experiments are underway
to isolate and identify POMC peptides in normal human skin as well
as in epidermal melanocytes and keratinocytes.
In summary, our data indicate the expression of POMC mRNA in
normal human skin as well as in melanocytes and keratinocytes by in
situ hybridization. A µ300 bp RT-PCR product was found in normal
human skin, grafted human skin, and cultured melanocytes and
keratinocytes. Comparison of the sequence of RT-PCR product by
Genebank/Blast revealed 85% homology with human pituitary POMC
mRNA, suggesting the presence of an isoform/variant of POMC in
human skin.
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